Pyrovalerone

Molecular structure via molpic based on CDK

Conformer []

Conformer structure via 3Dmol.js

Physical properties []
Molecular mass	245.36 g/mol ^[1]
Predicted LogP	3.8 ^[1]

Structural Identifiers []
Molecular formula	C₁₆H₂₃NO ^[1]
IUPAC name	1-(4-methylphenyl)-2-pyrrolidin-1-ylpentan-1-one ^[1]
SMILES	CCCC(C(=O)C1=CC=C(C=C1)C)N2CCCC2 ^[1]
InChI	InChI=1S/C16H23NO/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14/h7-10,15H,3-6,11-12H2,1-2H3 ^[1]
InChIKey	SWUVZKWCOBGPTH-UHFFFAOYSA-N ^[1]

Pyrovalerone

Pyrovalerone (also known as Pirovalerona, Pyrovaleronum, 4'-Methyl-2-(1-pyrrolidinyl)valerophenone, 1-Pentanone, 1-(4-methylphenyl)-2-(1-pyrrolidinyl)-, J8.659B, Valerophenone, 4'-methyl-2-(1-pyrrolidinyl)-, 1-(4-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one, 1-P-tolyl-1-oxo-2-pyrrolidino-n-pentane, 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one or DAA56349) is a stimulant substance of the pyrrolidinophenone class.

Chemistry

Salts []

Pyrovalerone is typically found in the form of its hydrochloride salt.

Stereochemistry []

(RS)-Pyrovalerone is a racemic mixture of the optical stereoisomers

Subjective effects []

Physical effects
Abnormal heartbeat Appetite suppression Dehydration Dry mouth Increased blood pressure Increased heart rate Increased libido Restless legs Shakiness Stamina enhancement Stimulation Teeth grinding Vasoconstriction

Cognitive effects
Analysis enhancement Cognitive euphoria Compulsive redosing Disinhibition Ego inflation Focus enhancement Increased music appreciation Mania Motivation enhancement Suggestibility suppression Thought acceleration Wakefulness

Legal status []

Australia: Pyrovalerone is a S4 substance.
Brazil: Pyrovalerone is a B1 substance.
Canada: Pyrovalerone is a Schedule IV substance.
United States: Pyrovalerone is a Schedule V substance.
United Kingdom: Pyrovalerone is a Class C substance.
Germany: Pyrovalerone is a Anlage II substance.

Anodyne